Determination of ecabet in human plasma by high-performance liquid chromatography–tandem mass spectrometry

Effect of a Combination of Ecabet Sodium and Cimetidine on Experimentally Induced Gastric Lesions and Gastric Mucosal Resistance to Ulcerogenic Agents in Rats.

T Noto, H Tamaki · Biological and Pharmaceutical Bulletin · 1995 · 52 citations · Full text

Inflammation, Gastrointestinal Peptide Hormone, Anti-inflammatory +13

Bacterial activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions

K Shibata, Aiko Hongo, Akira Yasoshima et al. · Antimicrobial Agents and Chemotherapy · 1995 · 47 citations · Full text

Bacteriology, Ecabet Sodium, Drug Resistance +17

Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori

Kazuo Shibata, Aiko Hongo, Mine Kinoshita · European Journal of Pharmacology · 1998 · 43 citations

Biochemistry, Medicine, Acting Antiulcer Drug +4

Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.

M Kinoshita, Eisuke Kume, Hajime Tamaki · Journal of Pharmacology and Experimental Therapeutics · 1995 · 39 citations

Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.

Yuichi Onoda, Mine Takido, Tetsuo MAGARIBUCHI et al. · The Japanese Journal of Pharmacology · 1990 · 38 citations · Full text